Literature DB >> 18928938

Patients with minimal hepatic encephalopathy have poor insight into their driving skills.

Jasmohan S Bajaj1, Kia Saeian, Muhammad Hafeezullah, Raymond G Hoffmann, Thomas A Hammeke.   

Abstract

BACKGROUND & AIMS: Minimal hepatic encephalopathy (MHE) is associated with impaired driving skills. It is not clear whether patients have insight into this. The Driving Behavior Survey (DBS) is a validated self- or observer-administered questionnaire. DBS consists of a total score (maximum, 104) and an attention-related driving skills section (maximum, 40). DBS was used to compare self-assessment with observer-assessment of driving skills in cirrhotic patients tested for MHE.
METHODS: Forty-seven nonalcoholic cirrhotic patients and 40 controls underwent psychometric tests, DBS, and driving simulation with navigation/driving tasks. An adult familiar with the subject's driving completed the DBS independently. Simulator performances, total DBS scores, and driving skill scores were compared between/within groups (MHE+, MHE-, and controls) with respect to self-assessment and observer assessment.
RESULTS: Thirty-six patients were MHE+ and 11 were MHE-. MHE+ had a significantly higher simulator crash (MHE+, 3; MHE-, 1.2; controls, 1.7; P = .001) and illegal turn rate (MHE+, 1.2; MHE-, 0.3; controls, 0.1; P = .0001). Despite this worse performance, MHE+ patients rated themselves similar to MHE- patients and control groups on total (P = .28) and driving skills scores (P = .19). Observer assessment in MHE+ was significantly lower for total (P = .0001) and driving skills (P = .0001) compared with observer assessment for MHE- patients and control groups. MHE+ patients were rated significantly lower on driving skills (34 vs 37; P = .02) and trended lower in the total score (P = .08) by observers compared with self-ratings. In contrast, MHE- and control groups rated themselves similar to their observers on driving skills and total DBS scores.
CONCLUSIONS: MHE patients have poor insight into their driving skills. A part of the MHE patient's clinical interview should be to increase awareness of this driving impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18928938     DOI: 10.1016/j.cgh.2008.05.025

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  26 in total

Review 1.  Minimal hepatic encephalopathy impairs quality of life.

Authors:  Swastik Agrawal; Sridharan Umapathy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-04

Review 2.  The diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Tianzuo Zhan; Wolfgang Stremmel
Journal:  Dtsch Arztebl Int       Date:  2012-03-09       Impact factor: 5.594

3.  An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.

Authors:  Takumi Kawaguchi; Takuro Suetsugu; Shyou Ogata; Minami Imanaga; Kumiko Ishii; Nao Esaki; Masako Sugimoto; Jyuri Otsuyama; Ayu Nagamatsu; Eitaro Taniguchi; Minoru Itou; Tetsuharu Oriishi; Shoko Iwasaki; Hiroko Miura; Takuji Torimura
Journal:  Biomed Rep       Date:  2016-03-23

4.  Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis.

Authors:  Jasmohan S Bajaj; Steven D Pinkerton; Arun J Sanyal; Douglas M Heuman
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

Review 5.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

6.  Driving simulation can improve insight into impaired driving skills in cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Douglas P Gibson; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Arun J Sanyal; James B Wade
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

7.  Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; James B Wade; Douglas P Gibson; Kia Saeian; Jacob A Wegelin; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Velimir Luketic; Arun J Sanyal
Journal:  Gastroenterology       Date:  2010-09-21       Impact factor: 22.682

8.  Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS norms.

Authors:  Jasmohan S Bajaj; Melanie B White; Ariel B Unser; Dinesh Ganapathy; Andrew Fagan; Edith A Gavis; Richard K Sterling; Douglas M Heuman; Scott Matherly; Puneet Puri; Arun J Sanyal; Velimir Luketic; Michael Fuchs; Muhammad S Siddiqui; R Todd Stravitz; Binu John; Leroy R Thacker; James B Wade
Journal:  Metab Brain Dis       Date:  2016-06-25       Impact factor: 3.584

9.  Minimal hepatic encephalopathy matters in daily life.

Authors:  Jasmohan S Bajaj
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

10.  Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.

Authors:  Jasmohan S Bajaj; Kia Saeian; Christine M Schubert; Muhammad Hafeezullah; Jose Franco; Rajiv R Varma; Douglas P Gibson; Raymond G Hoffmann; R Todd Stravitz; Douglas M Heuman; Richard K Sterling; Mitchell Shiffman; Allyne Topaz; Sherry Boyett; Debulon Bell; Arun J Sanyal
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.